Table II.
Results of percutaneous pulmonary valve implantation – literature review
| Author | Valve | No. of patients | Mean age [years] | Procedure success (%) | Follow-up [years] | Freedom from reintervention (%) | IE No. of patients | Improvement |
|---|---|---|---|---|---|---|---|---|
| Cheatham, USA, 2015 | Melody | 170 | 19 | NA | 4.5 | 76 | 3 | Exercise capacity, NYHA functional class |
| Borik, Canada, 2015 | Melody | 51 | 20 | NA | 4.5 | 68 | 1 | RV size and maximum oxygen consumption |
| Armstrong, USA, 2014 | Melody | 101 | 20 | 98 | 1.0 | 97 | 3 | NYHA functional class, tricuspid regurgitation |
| Butera, Italy, 2013 | Melody | 63 | 24 | 94 | 2.5 | 92 | 2 | RVEDV, RVEF, RVESV |
| Biernacka, Poland, 2015 | Melody SAPIEN |
40 20 |
25 | 93 | 1.7 | 90 | 4 | NYHA functional class, RVEDV, RVEF, maximum oxygen consumption |
| Lurz, UK, 2008, 2011 | Melody | 155 | 21 | 95 | 2.3 | 93–70 | 5 | RVEDV, RVEF, maximum oxygen consumption |
| Kenny, USA, 2011 (COMPASSION) | SAPIEN | 36 | 30 | 97 | 0.5 | 97 | 0 | NYHA functional class, RVEDV |
| Haas, Germany, 2015 | SAPIEN | 22 | 22 | 90 | 0.5 | NA | 0 | NYHA functional class |
IE – infective endocarditis, NYHA – New York Heart Association, RVEDV – right ventricular end-diastolic volume, RVEF – right ventricular ejection fraction, RVESV – right ventricular end-systolic volume.